Harbinger Venture Capital is an institutional investor (Conventional VCs) founded in 2000 and headquartered in Taipei, Taiwan. Harbinger Venture Management is early stage corporate venture capital arm of MiTAC-SYNNEX Group that makes investments in North America & Asia. It invests across multiple sectors engaged in the areas such as Semiconductor, Wireless, LED Technology, Photonics, Medical Devices, BioPharma, Social, Digital Media. Notable portfolio companies are Envivio, Cardival Medical, Crown Bioscience, Yeepay, Applied Optoelectronics etc. The firm typically invests between $1M to $5 M per company. Typical check size: $1M - $5 M. Notable portfolio companies: Envivio, Cardival Medical, Crown Bioscience, Yeepay, Applied Optoelectronics.

Stage

early-stage, mid-stage, early-stage, mid-stage

Check size

$1M - $5 M

HQ

Taipei, Taiwan

Founded

2000

Website

https://www.harbingervc.com/

LinkedIn

https://linkedin.com/company/harbinger-venture

Twitter

http://twitter.com/plusventures

What they look for

Startups optimizing opportunities between Greater China and USA; promising teams; high-tech startups or niche high-growth companies

Preparing to pitch Harbinger Venture Capital?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.